Eicosanoyl-5-hydroxytryptamide (EHT) prevents Alzheimer's disease-related cognitive and electrophysiological impairments in mice exposed to elevated concentrations of oligomeric beta-amyloid.
about
Eicosanoyl-5-hydroxytryptamide (EHT) prevents Alzheimer's disease-related cognitive and electrophysiological impairments in mice exposed to elevated concentrations of oligomeric beta-amyloid.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Eicosanoyl-5-hydroxytryptamide ...... ns of oligomeric beta-amyloid.
@en
Eicosanoyl-5-hydroxytryptamide
@nl
type
label
Eicosanoyl-5-hydroxytryptamide ...... ns of oligomeric beta-amyloid.
@en
Eicosanoyl-5-hydroxytryptamide
@nl
prefLabel
Eicosanoyl-5-hydroxytryptamide ...... ns of oligomeric beta-amyloid.
@en
Eicosanoyl-5-hydroxytryptamide
@nl
P2093
P2860
P50
P1433
P1476
Eicosanoyl-5-hydroxytryptamide ...... ns of oligomeric beta-amyloid.
@en
P2093
Adolfo Mazzeo
Agnieszka Staniszewski
Eduardo Pérez
Hong Zhang
Jeffry B Stock
Kristen L Huber
Maxwell Stock
Michael Voronkov
Scott L Melideo
P2860
P304
P356
10.1371/JOURNAL.PONE.0189413
P407
P577
2017-12-18T00:00:00Z